Getting Prescription Medicines and Using Pharmacies in the Netherlands

Start by identifying the Dutch supply category in the CBG Medicines Information Bank. UR means prescription-only and is supplied by a pharmacy against a valid prescription. UA means pharmacy-only without prescription because pharmacist advice/checks are required. UAD can be sold by a pharmacy or licensed drugstore; AV can be sold generally, often with pack-size or strength limits. The same ingredient can sit in different categories by strength, form or pack. Do not infer availability from a supermarket shelf or a foreign brand name.

For a new or high-risk symptom, pregnancy, breastfeeding, a child, older person, kidney/liver disease, allergy or several medicines, ask the pharmacist or GP before choosing self-care. Use Apotheek.nl and Thuisarts for Dutch decision aids. Call the GP or out-of-hours GP post for urgent problems; call 112 for life-threatening breathing difficulty, collapse, severe allergic reaction or dangerous poisoning symptoms. Do not treat an emergency by searching shops.

Choose a regular pharmacy through the Apotheek.nl finder, then verify it in the insurer's 2026 contracted-provider finder. Compare opening hours, accessibility/language, delivery, pickup locker, repeat service, compounding, medication review and the named dienstapotheek outside hours. Contracting is policy-specific: a national chain or online pharmacy is not automatically fully reimbursed. Register before an urgent prescription and save regular and out-of-hours numbers.

For online purchases, click the common EU logo and confirm that it opens the provider's entry in the official registered seller list. Check which category that seller is authorised to supply. Only an online pharmacy may supply prescription medicines, and a prescription is still required. A marketplace, social-media seller, copied logo, prescription medicine offered without prescription or two-for-one medicine promotion fails the check. Avoid importing by post until Dutch and sending-country rules are verified.

For a foreign medicine, record active ingredient, strength, dosage form, dose, indication and prescriber contact - not brand alone. Check Dutch authorisation and availability with the CBG database. A Dutch clinician may need to reassess treatment; an EU cross-border prescription can be usable if it includes full patient identity, date, prescriber name/qualification/contact/address/signature, generic substance, form, quantity, strength and dosage. Carry a paper copy because electronic systems do not automatically interoperate and the Dutch product/pack may differ.

Create a medicine-route card with category, prescriber, dispensing pharmacy, insurer contract, ordinary/out-of-hours route, price check and emergency threshold. Never borrow another person's prescription, split a modified-release product without approval or substitute a foreign internet source for clinical review.

Register one regular pharmacy and provide identity, address, insurer details, GP/specialists, allergies, intolerances, pregnancy/breastfeeding, kidney/liver conditions and every prescription, OTC medicine, vitamin, supplement and relevant substance. Ask how it obtains records from the previous pharmacy. Do not assume a national central file: each pharmacy, GP and hospital maintains its own record, while systems such as the Landelijk Schakelpunt exchange selected information only with the required permission/authorisation and participating providers.

Request a current medication overview from the pharmacy and compare it with GP and hospital portals. For every line verify active substance and brand, form, strength, dose, timing, reason, prescriber, start/stop date, allergies and adverse reactions. Mark what is actually taken, temporarily paused, used as needed or stopped. A dispensing history does not prove current use, and medicines bought elsewhere may be absent. Correct errors with the provider that owns the source record and ask it to propagate an updated overview where possible.

Before surgery, hospital admission, pregnancy care, vaccination, emergency treatment or a new specialist, bring the dated overview plus a short personal list. After discharge, reconcile the discharge prescription with what existed before: explicitly label continue, change, pause and stop; identify who monitors labs and who issues repeats. Ask the hospital to send the transfer and confirm the regular pharmacy received it. Never continue two strengths because both remain visible in separate portals.

When transferring pharmacy, ask the old and new pharmacies how the dossier and active repeats move, whether consent is needed, and when the transfer is complete. Keep enough supply without stockpiling. For a temporary pharmacy or out-of-hours pharmacy, take ID, insurance details, prescription, overview and allergies; expect that it may not see the full record. Give consent only after understanding what information, purpose, recipients and duration apply. You may ask a provider for access and correction under data-protection and healthcare-record rules.

Protect the record: use provider portals rather than ordinary email for sensitive documents where available; do not send a full phone backup or share DigiD. Keep a paper emergency list and encrypted copy accessible to a trusted person, but review consent and remove obsolete access. Record the date and source of every correction.

Schedule a medication review when there are many long-term medicines, falls/confusion, adherence problems, kidney changes, repeated side effects or transitions between providers. Bring actual packs and questions. A review should end with one agreed list, concrete changes, responsible prescriber/pharmacist, monitoring dates and a follow-up - not an unexplained deletion. Report new symptoms promptly rather than editing the list independently.

For a first prescription, confirm why the medicine is used, expected benefit and timing, dose/form/length, alternatives, monitoring, interactions and the action for missed doses or side effects. The prescriber sends a Dutch electronic prescription to the selected pharmacy or provides the required route; the pharmacy performs interaction, allergy, dose and duplication checks and gives first-supply counselling. Ask for the leaflet and a demonstration for inhalers, injections, eye drops or measuring devices. Do not leave until the label matches the agreed plan.

The first supply is often shorter so tolerability and response can be assessed. Record the review date and responsible clinician before it runs out. For repeat prescriptions, identify the owner: GP portal/phone, specialist, hospital pharmacy or pharmacy repeat service. Request early enough for clinical review and stock, but not so early that the insurer or prescriber rejects it. A pharmacy repeat service does not replace blood tests, blood-pressure checks or specialist review.

At hospital discharge, obtain a medication list and prescriptions before leaving. Ask which hospital-only medicine must be collected there, which goes to the community pharmacy, whether an expensive medicine has an authorisation arrangement, and who issues the next repeat. If the community pharmacy cannot see the prescription, contact the sending department rather than asking it to guess. Keep discharge phone numbers and confirmation.

For a foreign or EU prescription, ensure full name and birth date; issue date; prescriber's full name, qualification, contact, work address/country and signature; and generic substance, form, strength, quantity and dosage. Bring paper. The pharmacy applies Dutch law and may supply a different pack or smaller quantity; controlled medicines and products unavailable or unauthorised locally require further review. Reimbursement may require paying first and claiming from the insurer. A non-EU prescription or unclear remote prescription can require a Dutch assessment.

For monitored or dependency-forming medicines, agree one prescriber and pharmacy, collection interval, early/lost-dose policy, review and travel plan. Do not obtain overlapping supplies from multiple prescribers. If a dose is lost, stolen, vomited or missed, call the pharmacist/prescriber; do not double it unless the medicine-specific advice says so.

Track each request: medicine/strength, remaining doses, request date/channel, promised date, review/lab due, collection, price and problem. If a repeat is refused, ask the clinical reason and the safe bridging plan, not merely a new portal request. If supply is urgent, the pharmacist, GP or GP post decides an emergency supply from the clinical record; out-of-hours dispensing is substantially more expensive and is not a routine convenience service.

When the offered product differs, compare active substance, strength, dosage form, release mechanism, route, dose, pack and device. A generic normally contains the same active substance, but excipients, tablet appearance, inhaler technique, injection device and modified-release behaviour can matter. Ask the pharmacist to identify exactly what changed and demonstrate the device. Do not split, crush or interchange modified-release, enteric-coated, narrow-dose, biologic or device-dependent products without medicine-specific approval.

Insurer preference is not the same as a clinical shortage. If a preferred brand causes a documented adverse effect or unusable device problem, report dates, batch/product, symptoms, technique check and outcome; ask the prescriber whether medische noodzaak is justified and obtain the insurer's decision. Brand preference alone may not meet the test. For medicines such as thyroid, epilepsy, transplant, anticoagulant, biologic or certain psychiatric treatment, use prescriber/pharmacist monitoring appropriate to that medicine rather than a universal “never switch” rule.

For non-supply, ask the pharmacy whether the problem is local stock, wholesaler delay, national shortage, discontinued product, prescription error or insurer rejection. Check Farmanco for shortages pharmacists are experiencing and CBG information for expected supply problems. Farmanco generally records national unavailability expected to last over 14 days; a manufacturer notification does not always become a patient shortage. Do not drive between pharmacies until one confirms stock and lawful transfer.

Work through alternatives with pharmacist and prescriber: another pack or manufacturer; equivalent strength using a safe number of units; different formulation; pharmacy preparation; therapeutic alternative; or authorised import. Each can require a new prescription, dose instructions, monitoring and insurer approval. Import under a shortage/doctor's declaration is a professional regulatory route, not permission to order abroad personally. Ask who contacts whom and what supply bridges the decision.

Never ration, alternate days, double later, use expired stock or buy social-media medicine independently. If interruption creates immediate risk - insulin, anti-seizure medicine, steroids, anticoagulants, transplant medicines or another critical therapy - state remaining doses and clinical risk to the pharmacist/prescriber the same day; use the GP post for urgent clinical escalation and 112 for life-threatening deterioration.

Record shortage start, expected end, contacts, proposed substitution, clinical approval, new instructions, cost and follow-up. On collection check label and appearance and remove the obsolete version from the active list without discarding it until the pharmacist confirms safe disposal. Report suspected adverse reactions to the clinician and Lareb; the report supports safety monitoring but does not provide emergency care or compensation.

Check each product in Medicijnkosten.nl by exact active substance, strength, form and pack. The result shows whether it is in the basic-package/GVS, the average reimbursed amount, possible GVS co-payment and alternatives without co-payment. It does not show the final pharmacy bill: listed figures exclude the pharmacy dispensing-service fee, and insurer contracts, preferred-product policy and pharmacy choice change the result.

Current indicative service charges are about €6–€7 for an ordinary supply, €12–€15 for a first supply, and €35–€45 outside office hours. A pharmacy preparation adds roughly €18–€21 and a special preparation about €90–€120; actual contracted tariffs vary. First-supply counselling is a healthcare service, not a second charge for the tablets. Ask for an itemised invoice separating product, dispensing service, preparation and other care.

In 2026, covered medicine and dispensing costs can count toward the €385 compulsory deductible. A GVS co-payment is separate and capped at €250 per person per calendar year. Example: before meeting the deductible, a €20 covered product plus €13 first-supply service may be charged through the deductible; a separate €8 GVS co-payment counts toward the €250 cap, not the deductible. After the deductible is met, covered contracted costs may be reimbursed while co-payments continue until their own cap. Voluntary deductible and policy conditions can increase personal exposure.

Insurers may designate a preferred manufacturer. If that product is clinically usable, another brand can be unpaid or partly paid; a shortage may trigger an alternative. Medische noodzaak must be clinically supported by the prescriber and can still be reviewed under policy rules. Document the reaction or device problem precisely. Compare reimbursed alternatives, but do not switch strength, formulation, modified release, inhaler/device or biologic solely for price.

Before choosing a pharmacy, use the insurer's provider finder and read reimbursement for uncontracted care, online supply, compounding and out-of-hours services. Ask whether direct billing applies. For a non-covered prescription, request the cash price in advance. Check authorised manufacturer reimbursement schemes through the pharmacy; never give bank/health data to an unverified rebate site.

Reconcile the insurer explanation of benefits with the pharmacy invoice: date, medicine, service, deductible, co-payment and reimbursement. First dispute coding or contract facts with pharmacy/insurer in writing. For insurance reimbursement disputes use the insurer complaint process and then SKGZ where eligible. Keep prescription, invoice, policy, provider-finder screenshot and decision; a safety complaint and a payment dispute follow different routes.

At every new supply, read the pharmacy label and current leaflet and confirm medicine, person, strength, dose, route, timing, duration and indication. Ask what to do with food, alcohol, driving, sun, pregnancy/breastfeeding, other medicines and missed doses. Demonstrate technique and have the pharmacist watch you for inhalers, pens, injections, patches, eye drops and liquid measuring. Do not rely on colour because brands change.

Use one dosing system that preserves the prescription: alarm, chart, pill organiser or pharmacy individualised distribution where suitable. A distribution roll can cost roughly €16 for one week, €30 for two and €45 for three before insurer arrangements, and it does not include every as-needed, refrigerated or special medicine. Keep original labels and an updated list. Never move controlled or high-risk medicine into an unlabelled travel box without also carrying identifying documentation.

Store at the labelled temperature, away from children, moisture and heat. For refrigeration, use a thermometer and ask the pharmacy for the allowed excursion range before discarding or re-cooling; freezing may damage some products. During a power failure, keep the refrigerator closed and record time/temperature. Check expiry after opening for drops, liquids, insulin and compounded products. Never share medicines.

Before adding OTC medicine, vitamins, herbs, cannabis/CBD or supplements, ask the pharmacist to screen interactions. Pay special attention to duplicate paracetamol/NSAIDs, sedatives, blood thinners, antidepressants, lithium, seizure, transplant and diabetes treatment. Pregnancy, breastfeeding, kidney/liver disease and children change safe choices. Use Apotheek.nl, the CBG leaflet database and Thuisarts; do not use an influencer or marketplace review as dosing evidence.

For a possible side effect, note start time, dose/change, symptoms, other exposures and severity. Call 112 for collapse, severe breathing trouble or anaphylaxis; call GP/GP post for urgent poisoning, severe reaction or dangerous mental/neurological change. For non-urgent effects, contact pharmacist/prescriber before stopping a medicine where abrupt withdrawal is risky. Lareb accepts suspected-reaction reports, but reporting does not replace treatment.

Return unused or expired medicine according to the municipality/pharmacy policy; many pharmacies accept it after removing personal labels and outer packaging, but local arrangements differ. Put needles and lancets in an approved sharps container, never loose in household waste. Do not flush medicine. Keep controlled medicines secure and report theft promptly.

Review the list after every hospital visit, new diagnosis, lab change, pregnancy, fall or care transition. Remove duplicates only after professional confirmation and document who decided. A safe medicine routine has one current list, one responsible repeat route, known monitoring dates, a shortage plan and emergency contacts - not merely a cupboard of labelled boxes.

For a dispensing error, wrong label, missing dose, unexpected substitution or damaged product, do not use it until the pharmacy checks it. Photograph pack/label, preserve receipt and batch, and state what was prescribed and taken. If a dose was already taken, ask pharmacist/clinician for immediate risk advice; call 112 for life-threatening symptoms or GP/GP post for urgent harm. Do not return a suspect pack to general stock before the facts are recorded.

Match the remedy to the problem. Clinical/service complaint: speak to the pharmacy, then use its free Wkkgz complaints officer; unresolved cases can go to the provider's recognised disputes body, which can issue a binding decision. Professional-conduct concerns may fit the healthcare disciplinary tribunal. Serious safety signals can be shared with Landelijk Meldpunt Zorg/IGJ, but IGJ does not settle an individual bill. Insurance/reimbursement disputes go through the insurer and then SKGZ. Suspected side effects go to Lareb. State the requested outcome - correction, safe supply, explanation, refund, record change or prevention - and keep deadlines/evidence.

Before travel, list destination and transit countries, medicine's active substance, dose, quantity, storage and whether it falls under the Dutch Opium Act. Use the CAK Medicines Travel Help and check the destination embassy/consulate because foreign import limits still apply. Keep medicine in original labelled packs, in hand luggage where airline rules allow, with medication overview, prescription/doctor letter and extra supply within lawful limits. Ask airline approval for needles, liquids and cooling equipment; do not rely on cabin crew refrigeration.

For covered controlled medicines in Schengen, the doctor signs/stamps the CAK form with BIG number and CAK approves it. A Schengen declaration is valid up to 30 days per medicine; longer trips can need multiple consecutive forms, while trips of 90 days or more use the English declaration route. Upload the signed form preferably at least a week before departure; an English declaration and embassy/legalisation route should be started preferably four weeks ahead. Include countries crossed outside airside transit.

If medicine is lost abroad, contact travel insurer assistance, local doctor/pharmacy and the Dutch prescriber/pharmacy; obtain police report for controlled/stolen stock and itemised receipts. A foreign replacement can have another name, strength or pack, so verify active substance and dose. Do not mail medicines or buy from an unregistered seller to solve the loss.

After any incident, update the medication overview, insurer claim and travel supply. Preserve complaint correspondence and medical harm records. Escalation should restore safe treatment first; compensation, discipline and system reporting are separate outcomes. If language or disability blocks access, request an interpreter or accessible channel and document the refusal rather than signing an explanation you do not understand.